The following IPOs are expected to price this week:
EQT Midstream Partners (EQM), which operates natural gas transportation and storage systems in the Appalachian Basin, plans to raise $250 million by offering 12.5 million shares at a price range of $19.00 to $21.00. At the midpoint of the proposed range, EQT Midstream Partners would command a market value of $708 million. EQT Midstream Partners, which was founded in 2012, booked $114 million in sales over the last 12 months. The Pittsburgh, PA-based company plans to list on the NYSE under the symbol EQM. Citi and Barclays are the joint bookrunners on the deal.
Exa Corporation (EXA), which provides performance simulation software for vehicle manufacturers, plans to raise $75 million by offering 6.3 million shares at a price range of $11.00 to $13.00. At the midpoint of the proposed range, Exa Corporation would command a market value of $177 million. Exa Corporation, which was founded in 1991, booked $47 million in sales over the last 12 months. The Burlington, MA-based company plans to list on the NASDAQ under the symbol EXA. Stifel Nicolaus Weisel is the lead bookrunner on the deal.
Loyalty Alliance Enterprise (LAEC), a provider of mobile direct marketing and customer loyalty solutions in China, plans to raise $36 million by offering 5.1 million shares at a price range of $6.00 to $8.00. At the midpoint of the proposed range, Loyalty Alliance Enterprise would command a market value of $105 million. Loyalty Alliance Enterprise, which was founded in 2009, booked $31 million in sales over the last 12 months. The Hong Kong-based company plans to list on the NASDAQ under the symbol LAEC. Macquarie Capital and Needham & Co. are the joint bookrunners on the deal.
ServiceNow (NOW), which provides an on-demand software platform to automate enterprise IT operations, plans to raise $186 million by offering 11.7 million shares at a price range of $15.00 to $17.00. At the midpoint of the proposed range, ServiceNow would command a market value of $2.4 billion. ServiceNow, which was founded in 2004, booked $150 million in sales over the last 12 months. The San Diego, CA-based company plans to list on the NYSE under the symbol NOW. Morgan Stanley, Citi, Deutsche Bank Securities and Barclays are the joint bookrunners on the deal.
Tesaro (TSRO), which is developing drugs for chemotherapy-induced nausea and solid tumors, plans to raise $81 million by offering 6.0 million shares at a price range of $12.00 to $15.00. At the midpoint of the proposed range, Tesaro would command a market value of $360 million. Tesaro, which was founded in 2010, booked $0 million in sales over the last 12 months. The Waltham, MA-based company plans to list on the NASDAQ under the symbol TSRO. Citi, Morgan Stanley and Leerink Swann are the joint bookrunners on the deal.
Renaissance Capital will have Pre-IPO Research available on each of these upcoming IPOs prior to its pricing.
